|
|
|
Volumn 11, Issue 12, 2008, Pages 855-856
|
|
EORTC-NCI-AACR - 20th symposium molecular targets and cancer therapeutics
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AEW 541;
ANG 1005;
ANTINEOPLASTIC AGENT;
AVE 1642;
AXITINIB;
BMS 754807;
DOXORUBICIN;
EZN 2968;
EZN 3920;
GHRELIN;
HORMONE RECEPTOR AFFECTING AGENT;
JNJ 26854165;
MOTESANIB;
PACLITAXEL;
SOMATOMEDIN C;
TZP 101;
UNCLASSIFIED DRUG;
VANDETANIB;
XL 184;
XL 228;
ABDOMINAL PAIN;
BLOOD BRAIN BARRIER;
BRAIN CANCER;
CACHEXIA;
CANCER THERAPY;
CONFERENCE PAPER;
CONSTIPATION;
DIARRHEA;
DRUG SAFETY;
DRUG TOLERABILITY;
GLIOBLASTOMA;
HUMAN;
LIVER CELL CARCINOMA;
LYMPHOMA;
METASTASIS;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NONHUMAN;
QT PROLONGATION;
THYROID CANCER;
VOMITING;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
CACHEXIA;
CLINICAL TRIALS, PHASE I AS TOPIC;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-MDM2;
TRANSFECTION;
|
|
EID: 57349181847
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
